Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples